Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.370
-0.250 (-6.91%)
May 29, 2026, 4:00 PM EDT - Market closed
Cryo-Cell International Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 31.28 | 31.57 | 31.99 | 31.34 | 30.34 | 28.88 | |
Revenue Growth (YoY) | -2.56% | -1.31% | 2.05% | 3.32% | 5.03% | -7.26% |
Cost of Revenue | 7.05 | 7.38 | 7.95 | 8.39 | 8.79 | 8.99 |
Gross Profit | 24.23 | 24.19 | 24.04 | 22.95 | 21.54 | 19.9 |
Selling, General & Admin | 18.59 | 18.22 | 18.52 | 17.17 | 15.58 | 14.61 |
Depreciation & Amortization Expenses | 0.74 | 0.75 | 0.48 | 1.12 | 1.12 | 0.83 |
Research & Development | 0.34 | 0.38 | 1.24 | 1.17 | 0.38 | 0.05 |
Other Operating Expenses | - | 4.36 | 0.31 | 15.79 | 0.44 | 0.38 |
Total Operating Expenses | 19.68 | 23.71 | 20.56 | 35.26 | 17.52 | 15.88 |
Operating Income | 0.19 | 0.48 | 3.48 | -12.3 | 4.02 | 4.02 |
Interest Expense | -2.03 | -2.07 | -1.86 | -1.24 | -1.52 | -1.38 |
Other Non-Operating Income (Expense) | -0.96 | -0.75 | 1.19 | 0.18 | 0.82 | -0.03 |
Total Non-Operating Income (Expense) | -2.99 | -2.82 | -0.68 | -1.06 | -0.71 | -1.41 |
Pretax Income | -2.8 | -2.34 | 2.8 | -13.36 | 3.32 | 2.61 |
Provision for Income Taxes | -0.14 | 0.09 | 2.4 | -3.84 | 0.55 | 0.53 |
Net Income | -2.67 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Net Income to Common | -2.67 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Net Income Growth | - | - | - | - | 33.02% | -42.52% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change (YoY) | -1.77% | -1.75% | -1.54% | -1.69% | 1.46% | 2.72% |
EPS (Basic) | -0.33 | -0.30 | 0.05 | -1.14 | 0.33 | 0.26 |
EPS (Diluted) | -0.33 | -0.30 | 0.05 | -1.14 | 0.33 | 0.25 |
EPS Growth | - | - | - | - | 32.00% | -44.44% |
Shares Outstanding | 8.06 | 8.06 | 8.08 | 8.29 | 8.5 | 8.55 |
Free Cash Flow | 4.94 | 5.25 | 3.61 | 2.08 | -3.6 | 6.09 |
Free Cash Flow Growth | -5.85% | 45.49% | 73.36% | - | - | -27.19% |
Free Cash Flow Per Share | 0.61 | 0.65 | 0.44 | 0.25 | -0.42 | 0.73 |
Dividends Per Share | 0.150 | 0.400 | 0.250 | - | - | - |
Dividend Growth | -62.50% | 60.00% | - | - | - | - |
Gross Margin | 77.47% | 76.63% | 75.15% | 73.23% | 71.02% | 68.88% |
Operating Margin | 0.61% | 1.53% | 10.88% | -39.26% | 13.27% | 13.91% |
Profit Margin | -8.52% | -7.70% | 1.26% | -30.38% | 9.14% | 7.21% |
FCF Margin | 15.80% | 16.63% | 11.28% | 6.64% | -11.85% | 21.09% |
EBITDA | 1.17 | 1.47 | 4.17 | -10.9 | 5.52 | 5.06 |
EBITDA Margin | 3.75% | 4.65% | 13.05% | -34.79% | 18.21% | 17.51% |
EBIT | 0.19 | 0.48 | 3.48 | -12.3 | 4.02 | 4.02 |
EBIT Margin | 0.61% | 1.53% | 10.88% | -39.26% | 13.27% | 13.91% |
Effective Tax Rate | 4.84% | -3.95% | 85.66% | 28.75% | 16.50% | 20.21% |